Is the lack of transparency in clinical trials making it easy for Big Pharma to Misrepresent products? Taking Tamiflu’s story of an “industry accepted” practice of selective dissemination of clinical trial results, inconsistencies, and cover ups, this article describes a pivotal moment in the history of medicine, calling for a change in legislation as well as a cultural shift. Are we ready to push for this change? Read more here. (Source: Ben Goldacre, The Guardian, 4/9/14).
You are here: / / Clinical Trials Lack Of Transparency – How easy is it to Misrepresent a Product? One Word – Tamiflu